Chemical activators of sphingomyelin phosphodiesterase 5 (SMPD5) engage with the enzyme to facilitate its role in sphingolipid metabolism. Sphingosine, a natural substrate of SMPD5, upon phosphorylation, forms sphingosine-1-phosphate, which is vital for intracellular signaling. C8-ceramide and C6-ceramide, both synthetic analogs of natural ceramide, serve as substrates that SMPD5 can convert to sphingosine. By providing compatible substrates that SMPD5 can process, these ceramides enhance the activity of the enzyme. Phytosphingosine, another sphingolipid, can be deacylated to yield a sphingoid base, which SMPD5 can utilize, thus promoting the enzyme's catalytic action. Similarly, D-erythro-sphingosine acts as a substrate for SMPD5, with its phosphorylated form playing a role in cellular signaling. Sphingomyelin, the namesake substrate of the enzyme, is directly hydrolyzed by SMPD5 into ceramide and phosphocholine, which are critical components in cell signaling pathways.
Further, sphingosylphosphorylcholine is a metabolite that SMPD5 can process, leading to the production of signaling molecules. Fumonisin B1, by inhibiting ceramide synthase, causes an accumulation of sphingoid bases, thereby enhancing substrate availability for SMPD5. Ceranib-2 indirectly affects SMPD5 activity by inhibiting ceramidase, leading to increased ceramide levels, which can serve as substrates for SMPD5. PDMP, by inhibiting glucosylceramide synthase, may also lead to increased ceramide levels, augmenting the substrate pool for SMPD5's sphingomyelin degradation activity. Ceramide trihexoside, upon breakdown, contributes to the ceramide pool, potentially activating SMPD5. C2-ceramide, a short-chain ceramide, can be readily utilized by SMPD5, thus supporting the enzyme's function in the metabolic breakdown of sphingolipids. These chemical activators collectively ensure the active participation of SMPD5 in the dynamic regulation of sphingolipid concentrations within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
Sphingosine serves as a substrate for SMPD5, and upon phosphorylation, it can produce sphingosine-1-phosphate (S1P), which activates intracellular signaling pathways that are linked to the enzymatic function of SMPD5. This activation promotes the catalytic action of SMPD5 in the breakdown of sphingomyelin to ceramide and phosphocholine. | ||||||
C-8 Ceramide | 74713-59-0 | sc-205233 sc-205233A sc-205233B | 1 mg 5 mg 25 mg | $19.00 $63.00 $228.00 | 1 | |
C8-ceramide can mimic the structure of natural ceramide, potentially activating SMPD5 by providing a compatible substrate that can be readily converted by the enzyme, thereby enhancing its activity in sphingolipid metabolism. | ||||||
Phytosphingosine | 554-62-1 | sc-201385 sc-201385A | 5 mg 25 mg | $102.00 $427.00 | 4 | |
Phytosphingosine is a sphingolipid that can be deacylated to produce a sphingoid base, which may serve as a substrate for SMPD5, thus activating the enzyme's catalytic function in sphingolipid metabolism. | ||||||
Sphingomyelin | 85187-10-6 | sc-201381 sc-201381A | 100 mg 500 mg | $180.00 $560.00 | 3 | |
Sphingomyelin can directly engage with SMPD5 as a substrate, activating the enzyme to catalyze the hydrolysis of sphingomyelin into ceramide and phosphocholine, which are involved in various signaling pathways. | ||||||
Sphingosylphosphorylcholine, D-erythro | 1670-26-4 | sc-201384 | 10 mg | $408.00 | 1 | |
Sphingosylphosphorylcholine can be metabolized by SMPD5, activating the enzyme's function in the catabolism of sphingolipids, leading to the production of bioactive lipid signaling molecules. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
Fumonisin B1 inhibits ceramide synthase, leading to an accumulation of sphingoid bases, which could potentially enhance the substrate availability for SMPD5, thereby activating the enzyme's catalytic role in sphingolipid metabolism. | ||||||
Ceranib-2 | 1402830-75-4 | sc-507503 | 10 mg | $173.00 | ||
Ceranib-2 is an inhibitor of ceramidase, which could lead to increased levels of ceramide, potentially enhancing the substrate availability for SMPD5 and activating the enzyme's catalytic role in sphingolipid breakdown. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
C2-ceramide is a short-chain, cell-permeable ceramide that can be utilized as a substrate by SMPD5, thus activating the enzyme and promoting its function in the catabolic processes of sphingolipid metabolism. | ||||||